In a revolutionary stride towards advancing consumer electrocardiogram (ECG) diagnostics, Belfast-based medical technology company PulseAI unveiled a groundbreaking artificial intelligence (AI) algorithm, empowering individuals to proactively assess and understand their heart health with enhanced precision. This cutting-edge technology that combines AI with ECG data is poised to redefine the landscape of cardiac health monitoring, says GlobalData, a leading data and analytics company.
With this transformative development, PulseAI not only addresses the imperative “what” of improved ECG diagnostics but also the critical “who” – consumers seeking comprehensive, accessible, and actionable insights into their heart health.
Kamilla Kan, Senior Data Scientist at GlobalData, comments: “This groundbreaking solution from PulseAI marks a pivotal moment in the intersection of healthcare and technology, ushering in a new era where advanced AI algorithms empower individuals to take charge of their cardiovascular well-being.”
According to GlobalData, the AI market was worth $81.3 billion in 2022 and is forecast to record a compound annual growth rate (CAGR) of 35.2% to reach $908.7 billion by 2030.
PulseAI’s AI algorithm exemplifies the transformative impact of AI on the healthcare industry. The past years have especially underscored the critical importance of AI in the healthcare industry, particularly during the COVID-19 pandemic, where advanced algorithms played a pivotal role in accelerating diagnostics, drug discovery, and patient care, providing invaluable support to overwhelmed healthcare systems worldwide.
Kan concludes: “As we witness the convergence of technology and health, the unveiling of such innovative solutions not only signals a remarkable advancement in cardiac monitoring but also highlights the growing importance of AI in fostering personalized, accessible healthcare.”
